GSA Capital Partners’s Wave Life Sciences WVE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-12,643
| Closed | -$102K | – | 2203 |
|
2025
Q1 | $102K | Buy |
+12,643
| New | +$102K | 0.01% | 1494 |
|
2024
Q4 | – | Sell |
-63,513
| Closed | -$521K | – | 2077 |
|
2024
Q3 | $521K | Buy |
63,513
+8,255
| +15% | +$67.7K | 0.04% | 870 |
|
2024
Q2 | $276K | Sell |
55,258
-39,779
| -42% | -$199K | 0.02% | 1314 |
|
2024
Q1 | $586K | Buy |
+95,037
| New | +$586K | 0.05% | 789 |
|
2023
Q3 | – | Sell |
-83,210
| Closed | -$303K | – | 1964 |
|
2023
Q2 | $303K | Buy |
+83,210
| New | +$303K | 0.03% | 1045 |
|
2022
Q2 | – | Sell |
-196,887
| Closed | -$394K | – | 1853 |
|
2022
Q1 | $394K | Buy |
196,887
+23,242
| +13% | +$46.5K | 0.05% | 711 |
|
2021
Q4 | $545K | Buy |
173,645
+140,876
| +430% | +$442K | 0.07% | 537 |
|
2021
Q3 | $161K | Buy |
+32,769
| New | +$161K | 0.02% | 1276 |
|
2018
Q4 | – | Sell |
-7,600
| Closed | -$380K | – | 1787 |
|
2018
Q3 | $380K | Sell |
7,600
-1,900
| -20% | -$95K | 0.02% | 1211 |
|
2018
Q2 | $363K | Sell |
9,500
-10,600
| -53% | -$405K | 0.02% | 1306 |
|
2018
Q1 | $806K | Buy |
20,100
+9,200
| +84% | +$369K | 0.04% | 797 |
|
2017
Q4 | $383K | Buy |
+10,900
| New | +$383K | 0.02% | 1083 |
|